» Articles » PMID: 20049564

Characterization of Chronic Idiopathic Thrombocytopenic Purpura in Japanese Children: a Retrospective Multi-center Study

Abstract

The objectives of this study are to clarify (1) the difference in demographic and clinical variables at initial presentation between acute and chronic idiopathic thrombocytopenic purpura (ITP), and (2) the prognostic factors of patients with chronic ITP. We conducted a retrospective analysis of 247 children with newly diagnosed ITP between April 1991 and March 2006 who visited one of the 12 hospitals belonging to the Kyoto University Pediatric Hematologic Study Group. 180 and 67 cases were classified as the acute type and as the chronic type, respectively. Older age, higher initial platelet count, positive medical history or concomitant medical diagnosis, the absence of preceding infection or vaccination, and the absence of an increase in immunoglobulin were risk factors for the chronicity. The prognostic factors in chronic ITP were evaluated in 53 patients after excluding patients receiving splenectomy or having insufficient follow-up data. The overall time required for 50% resolution in patients with chronic ITP was approximately 5.6 years. Age at presentation of less than 3 years and higher platelet counts at the time of chronic ITP diagnosis were good prognostic factors. On the other hand, gender, initial platelet counts, and preceding infection or vaccination were not associated with the prognosis.

Citing Articles

Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia.

Schifferli A, Le Gavrian G, Aladjidi N, Moulis G, Godeau B, Leblanc T Blood Adv. 2024; 8(24):6183-6194.

PMID: 39374586 PMC: 11696666. DOI: 10.1182/bloodadvances.2024014381.


Predictors of Remission in Severe Childhood Immune Thrombocytopenia.

Cheng C, Yang Y, Yeh Y, Chen L, Chen J, Lin Y Diagnostics (Basel). 2023; 13(3).

PMID: 36766447 PMC: 9914323. DOI: 10.3390/diagnostics13030341.


Long-term efficacy and safety profile of splenectomy for pediatric chronic immune thrombocytopenia.

Isshiki K, Mori M, Irikura T, Ishikawa T, Honda M, Kaneko R Int J Hematol. 2023; 117(5):774-780.

PMID: 36622550 DOI: 10.1007/s12185-022-03529-z.


Chronic Pediatric Immune Thrombocytopenia Is Not Associated With Herpes Virus Infection Status.

Li T, Yan G, Luo Z, Xie Q, Lai M, Chen Z Front Pediatr. 2021; 9:641535.

PMID: 34926334 PMC: 8678596. DOI: 10.3389/fped.2021.641535.


Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Provan D, Arnold D, Bussel J, Chong B, Cooper N, Gernsheimer T Blood Adv. 2019; 3(22):3780-3817.

PMID: 31770441 PMC: 6880896. DOI: 10.1182/bloodadvances.2019000812.


References
1.
Reid M . Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome. Arch Dis Child. 1995; 72(2):125-8. PMC: 1511010. DOI: 10.1136/adc.72.2.125. View

2.
Wendtland Edslev P, Rosthoj S, Treutiger I, Rajantie J, Zeller B, Jonsson O . A clinical score predicting a brief and uneventful course of newly diagnosed idiopathic thrombocytopenic purpura in children. Br J Haematol. 2007; 138(4):513-6. DOI: 10.1111/j.1365-2141.2007.06682.x. View

3.
Imbach P, Kuhne T, Muller D, Berchtold W, Zimmerman S, Elalfy M . Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer. 2005; 46(3):351-6. DOI: 10.1002/pbc.20453. View

4.
Lowe E, Buchanan G . Idiopathic thrombocytopenic purpura diagnosed during the second decade of life. J Pediatr. 2002; 141(2):253-8. DOI: 10.1067/mpd.2002.125909. View

5.
Kuhne T, Buchanan G, Zimmerman S, Michaels L, Kohan R, Berchtold W . A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr. 2003; 143(5):605-8. DOI: 10.1067/s0022-3476(03)00535-3. View